<?xml version="1.0" encoding="UTF-8"?>
<p id="P35">Survival outcomes associated with CC-486 maintenance were also relatively favorable. Median OS was not reached in any dosing cohort at a median follow-up of 19 months, and estimated 1-year survival rates were above 80%.</p>
